| Code | 6626D | ||||||||||
| MA number | 42/0036/21-S | ||||||||||
| Product Form: | plv ifo 10x250 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 17.02.2021 |
| Validity: | 17.02.2026 |
| MA renewed: | Renewal application submitted |
| Pediatric posology: | Yes |
| PIL: |
PIL_MEDOVIR 250 mg_plv ifo_04.2021.pdf
|
| SPC: |
SPC_MEDOVIR 250 mg_plv ifo_04.2021.pdf
|
| Safety feature | Yes |
| Data update: | 01.03.2021 |
